Brief: Jw Cayman Therapeutics Announces Of Potential Substantial Shareholder Change
21/05/2021 02:16
May 21 (Reuters) - Jw Cayman Therapeutics Co Ltd 2126.HK :
* SYRACUSE CAYMAN INFORMS ITS APPROVED ADVISABILITY OF DEALS
THAT
WOULD RESULT IN DISTRIBUTION OR SALE OF CO'S SHARES HELD
Source text for Eikon: urn:newsml:reuters.com:*:nHKS4RNSSW
Further company coverage: 2126.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on JW (Cayman) Therapeutics Co
See all newsChina pharma industry not impacted by Beijing scrutiny of sensitive tech deals, JW chief says
Brief: JW (Cayman) Therapeutics Appoints Tian Feng As CEO, Executive Director
Australia's Imugene gains on alliance with JW Therapeutics for tumour treatment
Brief: JW (Cayman) Therapeutics H1 Net Income RMB -267.3 Million
Brief: JW (Cayman) Therapeutics Grants Juno Therapeutics Non-Exclusive License